Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2013, Article ID 461041, 5 pages
http://dx.doi.org/10.1155/2013/461041
Research Article

Quality of Life Study following Cytoreductive Surgery and Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei including Redo Procedures

1Hepatobiliary and Surgical Oncology Unit, UNSW Department of Surgery, St. George Hospital, Sydney, NSW 2217, Australia
2Cancer Care Centre, St. George Hospital, Sydney, NSW 2217, Australia
3UNSW Department of Surgery, St. George Hospital, Sydney, NSW 2217, Australia
4The University of New South Wales, Department of Surgery, St. George Hospital, Kogarah, Sydney, NSW 2217, Australia

Received 17 February 2013; Revised 14 April 2013; Accepted 24 June 2013

Academic Editor: Perry Shen

Copyright © 2013 Rachel Kirby et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. H. Sugarbaker, “Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome,” European Journal of Surgical Oncology, vol. 27, no. 3, pp. 239–243, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. P. H. Sugarbaker, “New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?” Lancet Oncology, vol. 7, no. 1, pp. 69–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. K. E. Bevan, F. Mohamed, and B. J. Moran, “Pseudomyxoma peritonei,” World Journal of Gastrointestinal Oncology, vol. 2, no. 1, pp. 44–50, 2010. View at Google Scholar
  4. R. M. Smeenk, V. J. Verwaal, N. Antonini, and F. A. N. Zoetmulder, “Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy,” Annals of Surgery, vol. 245, no. 1, pp. 104–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Deraco, D. Baratti, M. G. Inglese et al., “Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei,” Annals of Surgical Oncology, vol. 11, no. 4, pp. 393–398, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Güner, U. Schmidt, M. H. Dahlke, H. J. Schlitt, J. Klempnauer, and P. Piso, “Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei,” International Journal of Colorectal Disease, vol. 20, no. 2, pp. 155–160, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. L. Van Leeuwen, W. Graf, L. Pahlman, and H. Mahteme, “Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis,” Annals of Surgical Oncology, vol. 15, no. 3, pp. 745–753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Vaira, T. Cioppa, G. De Marco et al., “Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience,” In Vivo, vol. 23, no. 4, pp. 639–644, 2009. View at Google Scholar · View at Scopus
  9. B. Moran, D. Baratti, T. D. Yan, S. Kusamura, and M. Deraco, “Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei),” Journal of Surgical Oncology, vol. 98, no. 4, pp. 277–282, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Bryant, A. J. Clegg, M. K. Sidhu, H. Brodin, P. Royle, and P. Davidson, “Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei,” Health Technology Assessment, vol. 8, no. 7, pp. 1–54, 2004. View at Google Scholar · View at Scopus
  11. T. D. Yan, D. Black, R. Savady, and P. H. Sugarbaker, “A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei,” Annals of Surgical Oncology, vol. 14, no. 2, pp. 484–492, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Yan, S. R. Pestieau, B. M. Shmookler, and P. H. Sugarbaker, “Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation,” Modern Pathology, vol. 14, no. 3, pp. 164–171, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. P. H. Sugarbaker, “Peritonectomy procedures,” Annals of Surgery, vol. 221, no. 1, pp. 29–42, 1995. View at Google Scholar · View at Scopus
  14. R. P. McQuellon, B. W. Loggie, R. A. Fleming, G. B. Russell, A. B. Lehman, and T. D. Rambo, “Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis,” European Journal of Surgical Oncology, vol. 27, no. 1, pp. 65–73, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. R. P. McQuellon, B. W. Loggie, A. B. Lehman et al., “Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis,” Annals of Surgical Oncology, vol. 10, no. 2, pp. 155–162, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. U. Schmidt, M. H. Dahlke, J. Klempnauer, H. J. Schlitt, and P. Piso, “Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy,” European Journal of Surgical Oncology, vol. 31, no. 1, pp. 53–58, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Piso, G. Glockzin, P. Von Breitenbuch et al., “Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies,” Journal of Surgical Oncology, vol. 100, no. 4, pp. 317–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. R. Hill, R. P. McQuellon, G. B. Russell, P. Shen, J. H. Stewart IV, and E. A. Levine, “Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin,” Annals of Surgical Oncology, vol. 18, no. 13, pp. 3673–3679, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. T. M. Tuttle, Y. Zhang, E. Greeno, and A. Knutsen, “Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy,” Annals of Surgical Oncology, vol. 13, no. 12, pp. 1627–1632, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Jess, L. H. Iversen, M. B. Nielsen, F. Hansen, S. Laurberg, and P. C. Rasmussen, “Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study,” Diseases of the Colon and Rectum, vol. 51, no. 6, pp. 868–874, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. O. Glehen, D. Osinsky, E. Cotte et al., “Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures,” Annals of Surgical Oncology, vol. 10, no. 8, pp. 863–869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Kusamura, R. Younan, D. Baratti et al., “Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique,” Cancer, vol. 106, no. 5, pp. 1144–1153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Hansson, W. Graf, L. Påhlman, P. Nygren, and H. Mahteme, “Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy,” European Journal of Surgical Oncology, vol. 35, no. 2, pp. 202–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Youssef, C. Newman, K. Chandrakumaran, F. Mohamed, T. D. Cecil, and B. J. Moran, “Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin,” Diseases of the Colon and Rectum, vol. 54, no. 3, pp. 293–299, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. G. Kerscher, J. Mallalieu, A. Pitroff, F. Kerscher, and J. Esquivel, “Morbidity and mortality of 109 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC) performed at a community hospital,” World Journal of Surgery, vol. 34, no. 1, pp. 62–69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Alves, F. Mohamed, G. Yadegarfar, H. Youssef, and B. J. Moran, “Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei,” European Journal of Surgical Oncology, vol. 36, no. 12, pp. 1156–1161, 2010. View at Google Scholar · View at Scopus
  27. P. H. Sugarbaker, A. Casado-Adam, R. Alderman, O. A. Stuart, and D. Chang, “Gastorintestinal complications in 147 Consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy,” International Journal of Surgical Oncology, vol. 2011, Article ID 468698, 10 pages, 2011. View at Publisher · View at Google Scholar
  28. T. C. Chua, T. D. Yan, A. Saxena, and D. L. Morris, “Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality,” Annals of Surgery, vol. 249, no. 6, pp. 900–907, 2009. View at Publisher · View at Google Scholar · View at Scopus